Latest return on equity
Monte Rosa Therapeutics Return on equity
Direct answer
Monte Rosa Therapeutics's return on equity is -42.66%.
The verified market snapshot reports -42.66%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 6, 2026.
Get free Monte Rosa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -42.66%
Explore related company data
View Monte Rosa Therapeutics's market capitalizationView Monte Rosa Therapeutics's price-to-book ratioView Monte Rosa Therapeutics's 52-week price rangeView Monte Rosa Therapeutics's revenue growthView Monte Rosa Therapeutics's profit marginView Monte Rosa Therapeutics's debt-to-equity ratioView all Monte Rosa Therapeutics key metricsReturn to Monte Rosa Therapeutics profile